From FDA OKs Akcea Rare Disease Drug, Setting Up Market Clash with Alnylam:

inotersen (Tegsedi)
inotersen (Tegsedi)

Inotersen (Tegsedi), an Akcea Therapeutics drug. Photo by Akcea.